GVHD approval positions Ryoncil for a label extension to treat covid on the back of a successful trial. I'm suggesting that you underestimate the value of this 'fast track' and the market reaction will be stronger than you suspect. Additionally, GVHD is the primary focus for MSB as they know the importance of having an FDA approved treatment and the cash flow that will generate. GVHD approval is an absolute game changer for MSB and the market knows it.
GVHD approval positions Ryoncil for a label extension to treat...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
0.035(2.89%) |
Mkt cap ! $1.421B | |||
| Open | High | Low | Value | Volume |
| $1.21 | $1.25 | $1.18 | $4.096M | 3.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22000 | $1.24 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 36989 | 4 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |